Development of medical countermeasures to mitigate or treat the gastrointestinal acute radiation syndrome after a nuclear or radiation incident

Ended Definitive Contract Awarded Last action

Contract number
HHSN272201300030C
Awardee
Awarding agency
Obligated
$7,041,180

Award facts

Opportunity
Contract value 100% obligated
$7,041,180.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition · 10 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Princeton, NJ, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action 9 $284,430
Other Administrative Action 8 $0
Funding Only Action 7 $290,812
Exercise an Option 6 $2,168,425
Other Administrative Action 5 $0
Other Administrative Action 4 $0
Exercise an Option 3 $2,165,100
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $2,132,413

Quick answers

Who was awarded contract HHSN272201300030C?

HHSN272201300030C was awarded to Soligenix, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 24, 2013.

How much is contract HHSN272201300030C worth?

The government has obligated $7,041,180 on HHSN272201300030C.

Was contract HHSN272201300030C competed?

The extent of competition for HHSN272201300030C was full and open competition. The government received 10 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login